The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Zaytseva O.V.
Helmholtz National Medical Research Center of Eye Diseases;
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Neroeva N.V.
Helmholtz National Medical Research Center of Eye Diseases
Okhotsimskaya T.D.
Helmholtz National Medical Research Center of Eye Diseases
Bobykin E.V.
Ural State Medical University
Anti-VEGF therapy for neovascular age-related macular degeneration: causes of incomplete response
Journal: Russian Annals of Ophthalmology. 2021;137(5): 152‑159
Views: 2307
Downloaded: 123
To cite this article:
Zaytseva OV, Neroeva NV, Okhotsimskaya TD, Bobykin EV. Anti-VEGF therapy for neovascular age-related macular degeneration: causes of incomplete response. Russian Annals of Ophthalmology.
2021;137(5):152‑159. (In Russ.)
https://doi.org/10.17116/oftalma2021137051152
Neovascular age-related macular degeneration (nAMD) is one of the leading causes of decreased vision in the elderly population in many countries, including Russia. Anti-VEGF therapy is undoubtedly the «gold standard» of treatment for the disease, but its use in different patients is known to produce results with significant interindividual differences. This article reviews modern ideas about the clinical assessment of the degree of response to anti-VEGF therapy, possible reasons for its insufficient effectiveness (clinical, pharmacological, or related to nAMD pathogenesis), discusses the potential applications of the existing therapeutic strategies, and considers the prospects for the emergence of new strategies that could be used for solving that problem.
Keywords:
Authors:
Zaytseva O.V.
Helmholtz National Medical Research Center of Eye Diseases;
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Neroeva N.V.
Helmholtz National Medical Research Center of Eye Diseases
Okhotsimskaya T.D.
Helmholtz National Medical Research Center of Eye Diseases
Bobykin E.V.
Ural State Medical University
Received:
09.07.2021
Accepted:
09.09.2021
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.